A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy

Post-Progression Survival in Secondary EGFR T790M-Mutated Non-Small-Cell Lung Cancer Patients With and Without Osimertinib After Failure of a Previous EGFR TKI

Targeted Oncology ◽

10.1007/s11523-020-00737-7 ◽

2020 ◽

Vol 15 (4) ◽

pp. 503-512

Author(s):

Chi-Lu Chiang ◽

Hsu-Ching Huang ◽

Chia-I Shen ◽

Yung-Hung Luo ◽

Yuh-Min Chen ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Tki ◽

P1.01-100 Effect of Osimertinib in Non-Small Cell Lung Cancer Patients with Brain Metastases After Progression Following Front-Line EGFR-TKI Therapy

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.815 ◽

2019 ◽

Vol 14 (10) ◽

pp. S400

Author(s):

X. Yu ◽

Y. Fan

Keyword(s):

Lung Cancer ◽

Brain Metastases ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Front Line ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Osimertinib in advanced or metastatic non-small cell lung cancer patients with EGFR T790M mutation after treatment with EGFR-TKI: Interim analysis of China cohort from the single-arm, open-label, international, multi-center real-world ASTRIS study

Annals of Oncology ◽

10.1093/annonc/mdy425.023 ◽

2018 ◽

Vol 29 ◽

pp. ix158

Author(s):

Q. Zhou ◽

H. Zhang ◽

L. Jiang ◽

Y. Shi ◽

Y. Chen ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Interim Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

T790m Mutation ◽

Lung Cancer Patients ◽

Egfr Tki ◽

EGFR-TKI Therapy Prolongs Survival In Non-small Cell Lung Cancer Patients With Brain Metastases or Bone Metastases

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2011.06.1853 ◽

2011 ◽

Vol 81 (2) ◽

pp. S621

Author(s):

L. Hui ◽

G. Xiaomei ◽

J. Wei ◽

B. Chunxue ◽

Z. Zhaochong

Keyword(s):

Lung Cancer ◽

Brain Metastases ◽

Small Cell Lung Cancer ◽

Bone Metastases ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Early Radiation Therapy Combined With EGFR-TKI Is Associated With Longer Survival in EGFR-Mutated Non-Small Cell Lung Cancer Patients With Brain Metastases

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.06.1725 ◽

2016 ◽

Vol 96 (2) ◽

pp. E436 ◽

Cited By ~ 1

Author(s):

Y. Liu ◽

L. Deng ◽

X. Zhou ◽

L. Zhou ◽

Y. Xu ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Brain Metastases ◽

Cancer Patients ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Early Radiation ◽

Egfr Mutated ◽

Findings and Outcomes from a Retrospective Study of Non-Small Cell Lung Cancer Patients with Synchronous Solitary Brain Metastases. An Analysis of Six Cases

The Open Cardiovascular and Thoracic Surgery Journal ◽

10.2174/1876533501205010038 ◽

2012 ◽

Vol 5 (1) ◽

pp. 38-42

Author(s):

Keigo Sekihara

Keyword(s):

Lung Cancer ◽

Retrospective Study ◽

Brain Metastases ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Solitary Brain Metastases

142P EGFR-TKI plus radiotherapy versus EGFR-TKI only in non-small cell lung cancer patients with brain metastasis: A systematic review and meta-analysis of observational studies

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(21)01984-5 ◽

2021 ◽

Vol 16 (4) ◽

pp. S774

Author(s):

A. Tancherla ◽

F. Wijovi ◽

T.I. Hariyanto ◽

A. Kurniawan ◽

A. Giselvania

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Brain Metastasis ◽

Cancer Patients ◽

Observational Studies ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Real‐World Utilization of EGFR TKIs and Prognostic Factors for Survival in EGFR‐Mutated Non‐Small Cell Lung Cancer Patients with Brain Metastases

International Journal of Cancer ◽

10.1002/ijc.33677 ◽

2021 ◽

Author(s):

Xiaoqing Yu ◽

Jiamin Sheng ◽

Guoqiang Pan ◽

Yun Fan

Keyword(s):

Lung Cancer ◽

Prognostic Factors ◽

Brain Metastases ◽

Cancer Patients ◽

Real World ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutated ◽

Egfr Tkis

Different characteristics and survival in non‐small cell lung cancer patients with primary and acquired EGFR T790M mutation

International Journal of Cancer ◽

10.1002/ijc.32015 ◽

2019 ◽

Vol 144 (11) ◽

pp. 2880-2886 ◽

Cited By ~ 6

Author(s):

Shuyuan Wang ◽

Bo Yan ◽

Yanwei Zhang ◽

Jianlin Xu ◽

Rong Qiao ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

T790m Mutation ◽

Lung Cancer Patients ◽

Different Characteristics ◽

Cystic Brain Metastases Occurring in Anaplastic Lymphoma Kinase Gene Rearranged Non–Small-Cell Lung Cancer Patients Receiving Crizotinib

Clinical Lung Cancer ◽

10.1016/j.cllc.2015.07.003 ◽

2016 ◽

Vol 17 (1) ◽

pp. 85-90 ◽

Cited By ~ 8

Author(s):

Vignesh Narayanan ◽

M. Justin Honce ◽

Sanjana Mehrotra ◽

D. Ross Camidge

Keyword(s):

Lung Cancer ◽

Brain Metastases ◽

Cancer Patients ◽

Anaplastic Lymphoma Kinase ◽

Small Cell ◽

Small Cell Lung ◽

Kinase Gene ◽

Lung Cancer Patients ◽

Anaplastic Lymphoma ◽

Anaplastic Lymphoma Kinase Gene